RXL Fund Description
The ProShares Ultra Health Care provides 2x leveraged exposure to a cap-weighted index of US health care companies.
RXL Factset Analytics Insight
RXL delivers daily 2x returns of the Dow Jones US Health Care Index, a broad, cap-weighted health care index that includes pharma, health care, biotech and insurance companies. Still, with pharma dominating the index, RXL is somewhat of a short-term bet on the movements in this industry. Investors should be cognizant of the fund's daily rebalancing, which can lead to profound differences in expected returns over the long haul. Still, compounding is a double-edged sword—it can work in investors' favor in trending markets. The fund has decent assets, but as with all tactical tools, liquidity is paramount. RXL tends to be a bit weak on that front, with middling volume and large spreads. The fund charges a high fee, like all leveraged ETFs, but holding costs are not the major issue for a fund like this.
RXL MSCI ESG Analytics Insight
The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of April 19, 2018 the ProShares Ultra Health Care MSCI ESG Fund Quality Score is 4.35 out of 10.
The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. RXL ranks in the 0th percentile within its peer group and in the 15th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.
RXL Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of RXL. RXL is rated a 5 out of 5.